Visits cost $250 with a physician and $175 with a nurse practitioner
Early-Phase Human Pharmacology: Urva et al., 2022 Urva, Coskun, Loh, and colleagues reported a phase 1b, multicenter, double-blind, placebo-controlled, randomized, multiple-ascending-dose trial in The Lancet in 2022 [3]
These studies will let us know more about how safe it is and how well it works when we compare it to other drugs
Dis Manag (2007) 10(3):12937.10.1089/dis.2007.103643 7 MaggardMAShugarmanLRSuttorpMMaglioneMSugermanHJLivingstonEHet alMeta-analysis: surgical treatment of obesity
Orders are fulfilled and shipped from Ontario, Canada
Appetite suppression with retatrutide is typically most effective at higher maintenance doses, so hunger is often more noticeable during the early titration phase